Largest pharmaceuticals by total liabilities
Everything the company owes, as its balance sheet stood at the end of the latest fiscal year.
Veradermics has the lowest figure of the 61 pharmaceuticals ranked by total liabilities, at CHF 7.7M, followed by Belite Bio (CHF 8.5M) and Oruka Therapeutics (CHF 14.1M). Figures as of 18 Nov 2026, 15:56 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- Lowest
- VeradermicsCHF 7.7M
- Median
- CHF 1.8B
- Combined market value
- CHF 4.28T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Total liabilities ↑ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | VeradermicsMANE · Health Care | CHF 7.7M | CHF 4.4B | CHF 104.10 | 1.69% down | 233% up | ||
| 2 | Belite BioBLTE · Health Care | CHF 8.5M | CHF 5.4B | CHF 133.56 | 0.48% up | 31% up | ||
| 3 | Oruka TherapeuticsORKA · Health Care | CHF 14.1M | CHF 5.5B | CHF 81.22 | 0.04% up | 241% up | ||
| 4 | Edgewise TherapeuticsEWTX · Health Care | CHF 25.6M | CHF 3.8B | CHF 34.40 | 2.93% down | 88% up | ||
| 5 | Dianthus TherapeuticsDNTH · Health Care | CHF 31.6M | CHF 4.1B | CHF 72.98 | 0.45% down | 113% up | ||
| 6 | Protagonist TherapeuticsPTGX · Health Care | CHF 45.1M | CHF 6.9B | CHF 105.03 | 0.04% down | 46% up | ||
| 7 | Praxis Precision MedicinesPRAX · Health Care | CHF 50.4M | CHF 7.2B | CHF 257.69 | 0.22% up | 61% up | ||
| 8 | Spyre TherapeuticsSYRE · Health Care | CHF 52.7M | CHF 7.6B | CHF 80.32 | 1.58% up | 286% up | ||
| 9 | ErascaERAS · Health Care | CHF 59.8M | CHF 3.9B | CHF 11.09 | 5.26% down | 403% up | ||
| 10 | Summit TherapeuticsSMMT · Health Care | CHF 77.8M | CHF 7.3B | CHF 9.12 | 1.41% up | 36% down | ||
| 11 | Definium TherapeuticsDFTX · Health Care | CHF 90.8M | CHF 3.3B | CHF 24.07 | 2.79% down | 169% up | ||
| 12 | ABIVAXABVX · Health Care | CHF 120.8M | CHF 6.2B | CHF 70.67 | 2.13% up | 27% down | ||
| 13 | Corcept TherapeuticsCORT · Health Care | CHF 159.2M | CHF 6.3B | CHF 57.59 | 2.48% down | 8% down | ||
| 14 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | CHF 165.2M | CHF 6.4B | CHF 80.86 | 0.87% up | 126% up | ||
| 15 | Rhythm PharmaceuticalsRYTM · Health Care | CHF 177.1M | CHF 6.8B | CHF 98.12 | 0.16% down | 13% up | ||
| 16 | Cogent BiosciencesCOGT · Health Care | CHF 253.9M | CHF 4.2B | CHF 23.98 | 2.15% up | 20% down | ||
| 17 | TG TherapeuticsTGTX · Health Care | CHF 350M | CHF 8.1B | CHF 53.76 | 1.72% up | 107% up | ||
| 18 | Roivant SciencesROIV · Health Care | CHF 350.9M | CHF 23.8B | CHF 32.86 | 0.72% up | 90% up | ||
| 19 | Travere TherapeuticsTVTX · Health Care | CHF 413.3M | CHF 4.1B | CHF 42.29 | 1.81% down | 44% up | ||
| 20 | Mirum PharmaceuticalsMIRM · Health Care | CHF 445.1M | CHF 5B | CHF 77.02 | 0.62% down | 31% up | ||
| 21 | Ligand PharmaceuticalsLGND · Health Care | CHF 458M | CHF 5B | CHF 251.32 | 1.49% up | 43% up | ||
| 22 | Axsome TherapeuticsAXSM · Health Care | CHF 507M | CHF 5.9B | CHF 111.68 | 2.53% down | 7% down | ||
| 23 | Madrigal PharmaceuticalsMDGL · Health Care | CHF 553.7M | CHF 8.1B | CHF 348.91 | 1.90% down | 24% down | ||
| 24 | AlkermesALKS · Health Care | CHF 562.8M | CHF 6.6B | CHF 39.22 | 2.38% up | 58% up | ||
| 25 | Legend BiotechLEGN · Health Care | CHF 616.6M | CHF 2.7B | CHF 13.69 | 0.81% up | 42% down | ||
| 26 | United TherapeuticsUTHR · Health Care | CHF 660.6M | CHF 20.6B | CHF 482.93 | 1.90% down | 23% up | ||
| 27 | Arrowhead PharmaceuticalsARWR · Health Care | CHF 743.3M | CHF 5.2B | CHF 36.68 | 1.22% up | 10% up | ||
| 28 | BioMarin PharmaceuticalBMRN · Health Care | CHF 1.3B | CHF 9.8B | CHF 50.60 | 2.60% up | 11% up | ||
| 29 | InsmedINSM · Health Care | CHF 1.3B | CHF 22.1B | CHF 100.83 | 1.83% down | 40% down | ||
| 30 | Ascendis PharmaASND · Health Care | CHF 1.4B | CHF 15B | CHF 228.42 | 0.07% down | 28% up | ||
| 31 | CytokineticsCYTK · Health Care | CHF 1.8B | CHF 6B | CHF 43.32 | 0.48% down | 20% down | ||
| 32 | Dr. Reddy's LaboratoriesRDY · Health Care | CHF 1.8B | CHF 10.5B | CHF 12.63 | 1.35% up | 5% up | ||
| 33 | BridgeBio PharmaBBIO · Health Care | CHF 2.5B | CHF 12.8B | CHF 65.48 | 1.16% up | 17% up | ||
| 34 | Ionis PharmaceuticalsIONS · Health Care | CHF 2.6B | CHF 3.8B | CHF 22.94 | 0.96% up | 64% down | ||
| 35 | PTC TherapeuticsPTCT · Health Care | CHF 2.6B | CHF 4.3B | CHF 50.93 | 0.12% up | 20% down | ||
| 36 | Amneal PharmaceuticalsAMRX · Health Care | CHF 3.1B | CHF 6.3B | CHF 18.21 | 2.27% up | 83% up | ||
| 37 | BeOne MedicinesONC · Health Care | CHF 3.2B | CHF 38.9B | CHF 340.90 | 2.13% down | 17% up | ||
| 38 | Alnylam PharmaceuticalsALNY · Health Care | CHF 3.5B | CHF 17.3B | CHF 129.26 | 2.01% down | 66% down | ||
| 39 | Elanco Animal HealthELAN · Health Care | CHF 5.7B | CHF 11.1B | CHF 22.20 | 1.90% up | 20% up | ||
| 40 | Vertex PharmaceuticalsVRTX · Health Care | CHF 5.9B | CHF 113.8B | CHF 448.98 | 0.28% down | 27% up | ||
| 41 | GenmabGMAB · Health Care | CHF 5.9B | CHF 26.8B | CHF 43.40 | 0.89% down | 70% up | ||
| 42 | Jazz PharmaceuticalsJAZZ · Health Care | CHF 6.2B | CHF 13.1B | CHF 204.70 | 0.90% up | 37% up | ||
| 43 | Regeneron PharmaceuticalsREGN · Health Care | CHF 7.8B | CHF 83.4B | CHF 805.99 | 0.15% down | 36% up | ||
| 44 | Royalty PharmaRPRX · Health Care | CHF 8.3B | CHF 33.2B | CHF 57.78 | 0.18% down | 78% up | ||
| 45 | ZoetisZTS · Health Care | CHF 10.2B | CHF 28.7B | CHF 70.59 | 0.33% up | 29% down | ||
| 46 | GrifolsGRFS · Health Care | CHF 11.3B | CHF 4.9B | CHF 7.19 | 1.22% down | 1% up | ||
| 47 | ViatrisVTRS · Health Care | CHF 18.9B | CHF 20B | CHF 17.46 | 1.30% up | 96% up | ||
| 48 | Teva Pharmaceutical IndustriesTEVA · Health Care | CHF 27.7B | CHF 41.8B | CHF 35.79 | 0.36% down | 74% up | ||
| 49 | Abbott LaboratoriesABT · Health Care | CHF 28.6B | CHF 151.6B | CHF 87.54 | 0.81% down | 17% down | ||
| 50 | Takeda PharmaceuticalTAK · Health Care | CHF 42.7B | CHF 57.5B | CHF 18.00 | 1.32% down | 54% up | ||
| 51 | Novo NordiskNVO · Health Care | CHF 43.6B | CHF 147.3B | CHF 33.43 | 2.56% down | 17% down | ||
| 52 | GSKGSK · Health Care | CHF 50.5B | CHF 82.6B | CHF 41.20 | 0.73% down | 6% up | ||
| 53 | SanofiSNY · Health Care | CHF 51.5B | CHF 95.7B | CHF 39.85 | 0.53% down | 4% down | ||
| 54 | NovartisNVS · Health Care | CHF 54.3B | CHF 249.1B | CHF 131.90 | 1.66% down | 25% up | ||
| 55 | AstraZenecaAZN · Health Care | CHF 55.1B | CHF 233.9B | CHF 150.78 | 1.85% down | 2% up | ||
| 56 | Bristol-Myers SquibbBMY · Health Care | CHF 60.3B | CHF 103.4B | CHF 50.57 | 2.20% down | 34% up | ||
| 57 | Merck & CoMRK · Health Care | CHF 71B | CHF 290.1B | CHF 117.66 | 2.63% down | 51% up | ||
| 58 | Eli LillyLLY · Health Care | CHF 72.4B | CHF 1.04T | CHF 1,171.13 | 1.84% down | 35% up | ||
| 59 | Johnson & JohnsonJNJ · Health Care | CHF 99.2B | CHF 557.7B | CHF 231.67 | 1.37% down | 38% up | ||
| 60 | PfizerPFE · Health Care | CHF 102.3B | CHF 135.4B | CHF 23.75 | 1.02% down | 14% up | ||
| 61 | AbbVieABBV · Health Care | CHF 115.6B | CHF 429.4B | CHF 242.90 | 1.58% down | 26% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total liabilities is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Where a company reports no total-liabilities line, it is worked out as assets less equity. Sums are converted from US dollars at today's exchange rate (1 USD = 0.8428 CHF).
Questions and answers
Which pharmaceuticals have the lowest total liabilities?
Veradermics (CHF 7.7M), Belite Bio (CHF 8.5M) and Oruka Therapeutics (CHF 14.1M) have the lowest total liabilities of the 61 pharmaceuticals ranked here as of 18 Nov 2026, 15:56 UTC.
How many pharmaceuticals are in this ranking?
61 are ranked by total liabilities.
What are these pharmaceuticals worth together?
The 61 pharmaceuticals ranked by total liabilities have a combined market value of CHF 4.28T as of 18 Nov 2026, 15:56 UTC.
What does ranking by total liabilities measure?
Everything the company owes, as its balance sheet stood at the end of the latest fiscal year.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest pharmaceuticals by total liabilities”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=total-liabilities
Underlying data: Yahoo Finance; SEC EDGAR.